medlogicai.org

Clinical intelligence. Better decisions.

Decision-Making Algorithm in Otorhinolaryngology & Head and Neck Surgery

Oral Cavity Carcinoma

The non-healing oral ulcer to a surgically-led cancer — depth of invasion, the elective neck, and reconstruction

Step 1

Step 1 of 14

Presentation & Risk Factors

Non-healing ulcer · pain/otalgia · loose teeth · tobacco/areca-nut/alcohol · OPMD (not HPV)

Oral cavity squamous cell carcinoma typically presents as a non-healing ulcer or lump in the tongue (most commonly the lateral border), floor of mouth, buccal mucosa, alveolus (gingiva), retromolar trigone, or hard palate — often indurated, with raised or rolled edges, and not healing after 2–3 weeks. Associated features include pain, referred otalgia, bleeding, loose teeth, ill-fitting dentures, dysphagia, a change in speech, trismus (suggesting deep or masticator-space involvement), and a neck mass from nodal metastasis.

The risk factors are dominated by tobacco (smoked and smokeless), areca nut / betel quid, and alcohol (tobacco and alcohol act synergistically), with oral potentially-malignant disorders (leukoplakia, erythroplakia, oral submucous fibrosis, proliferative verrucous leukoplakia, lichen planus) as premalignant precursors. A crucial distinction from oropharyngeal cancer is that oral cavity carcinoma is overwhelmingly carcinogen-driven, not HPV-driven — p16 positivity does not carry the favourable prognostic meaning here that it does in the tonsil and tongue base. A persistent oral lesion in an at-risk patient is cancer until biopsy says otherwise.

  • Non-healing indurated ulcer/lump — tongue (lateral border), FOM, buccal, alveolus, retromolar, palate
  • Pain, referred otalgia, bleeding, loose teeth, ill-fitting dentures, trismus, neck mass
  • Risk — tobacco (smoked/smokeless), areca nut/betel quid, alcohol (synergistic); OPMD precursors
  • Unlike oropharynx — carcinogen-driven, not HPV-driven (p16 not favourable here)

★ High-yield pearls (chapter-wide)

  • A mouth ulcer that has not healed in 2–3 weeks is oral cancer until biopsy proves otherwise — non-healing, indurated, or raised-edge ulcers are biopsied, not re-treated as aphthae.
  • Oral cavity carcinoma is a surgically-led disease — primary resection is the mainstay, in contrast to the organ-preservation chemoradiotherapy that leads in oropharynx and larynx.
  • Unlike oropharyngeal cancer, oral cavity carcinoma is overwhelmingly tobacco-, alcohol-, and areca-nut-driven, not HPV-driven — p16 does not carry the same favourable meaning here.
  • Depth of invasion is now part of T staging and is the strongest predictor of occult nodal metastasis — it, more than surface size, decides whether the clinically negative neck is electively treated.
  • Elective neck dissection improves survival over watchful waiting in early node-negative oral cancer — the D'Cruz trial settled this; the cN0 neck with meaningful depth is dissected, not observed.
  • Margins are measured on the fixed specimen and shrink — aim for a generous gross margin (≈1 cm) to land a clear (≥5 mm) histological margin, and use intra-operative frozen section.
  • Cortical bone invasion changes the operation — no invasion allows a marginal mandibulectomy, while cortical or marrow invasion mandates a segmental resection.
  • Positive margins or extranodal extension on final pathology mandate concurrent cisplatin chemoradiotherapy, not radiotherapy alone — the RTOG 9501 / EORTC 22931 high-risk features.
  • Areca nut (betel quid) causes oral submucous fibrosis, a premalignant condition of trismus and a pale, stiff mucosa — it is a major driver of oral cancer in South Asia and warrants surveillance.
  • Oral cancer field-cancerises — the whole mucosa is at risk, so multiple primaries, premalignant lesions, and second cancers are actively sought and followed lifelong.

Evidence base

4 sources
  1. MOD

    Ettinger KS, Ganry L, Fernandes RP · Oral Maxillofac Surg Clin North Am · 2019ReviewPMID 30454788

    Comprehensive review of oral cavity cancer — presentation, surgical management, the neck, reconstruction, and rehabilitation.

  2. HIGH

    Guha N, Warnakulasuriya S, Vlaanderen J · Int J Cancer · 2014Meta-analysisPMID 24302487

    Meta-analysis establishing betel quid (with and without tobacco) as a strong risk factor for oral cancer.

  3. MOD

    Mummudi N, Agarwal JP, Chatterjee S · Clin Oncol (R Coll Radiol) · 2019ReviewPMID 31174947

    Reviews the epidemiology and burden of oral cancer in the Indian subcontinent, driven by tobacco and areca nut.

  4. HIGH

    Lechner M, Liu J, Masterson L · Nat Rev Clin Oncol · 2022ReviewPMID 35105976

    Reviews HPV-driven oropharyngeal cancer — the contrast that explains why oral cavity cancer is carcinogen-driven and p16-status differs.

Decision tree

The triage screen is the first gate. Classification routes the stable patient to one of the aetiology-keyed pathways below. Cross-cut cards capture the chapter's must-not-miss rules.

Step 1 — TriageRed-flag screenNo red flagPathway classification?Premalignant (A)OPMD / OSMF — biopsy for dysplasia, cessation, surveillance,excise high-riskEarly (B)T1–T2 N0 — transoral resection + depth-driven elective neck(or SNB)Advanced resectable (C)T3–T4a / N+ — composite resection + neck + free flap +adjuvantMandible (D)No cortex → marginal; cortical/marrow invasion → segmental +fibulaNeck (E)cN0+depth → selective I–III (+IV tongue); cN+ → comprehensiveI–VReconstruction (F)Radial forearm (tongue/FOM) · fibula (segmental mandible,implants)Adjuvant (G)Intermediate → RT; positive margins / extranodal extension →cisplatin chemoRTUnresectable (H)T4b (masticator/skull base/carotid) / unfit → definitivechemoRT / palliationRecurrent/metastatic (I)Resectable recurrence → salvage; metastatic → pembrolizumab(CPS)Rehab / survivorship (J)Speech/swallow/dental rehab; second-primary watch; ORNpreventionPathways:A PremalignantB EarlyC Advanced resectableD MandibleE NeckF ReconstructionG AdjuvantH UnresectableI Recurrent/metastaticJ Rehab / survivorship
Step 1

Disclaimer

For educational purposes only. Not for clinical use. This platform is an instructional resource intended to support learning about clinical decision-making and the interpretation of investigations. Clinicians remain completely responsible for the interpretation of findings, the formulation of a differential diagnosis, and any clinical decision. Nothing in this application replaces individualized assessment, hands-on training, expert consultation, or established practice guidelines.

Not for profit effort by

Dr. Prahlada N.B

  • MBBS (JJMMC), MS (PGIMER, Chandigarh)
  • MBA in Hospital & Healthcare Management (BITS, Pilani)
  • Postgraduate Certificate in Technology Leadership and Innovation (MIT, USA)
  • Executive Programme in Strategic Management (IIM, Lucknow)
  • Senior Management Programme in Healthcare Management (IIM, Kozhikode)
  • Advanced Certificate in AI for Digital Health and Imaging Program (IISc, Bengaluru)

Supporting organisations

  • Karnataka ENT Hospital and Research Centre (R)
  • Champions Educational and Medical Society (R)
  • Amogh Foundation